Building a compounding capability requires a solid understanding of the regulatory environment associated with compounding and allocating the appropriate resources to ensure compounded medicines meet with the same high standards of safety and efficacy that are required for registered commercially available medicines.
Join GSK in shaping the future of Australian pharmacy at APP 2018. Explore the Shelf of the Future Be amongst the first to experience …
April marks the half-way point of the continuing professional development (CPD) year, which makes it a good time to review your plan, reflect on what …
The recent TGA changes to over-the-counter codeine-containing medicines is an opportunity to provide better care for patients who have been using OTC codeine. For some, …
Did you know that after 12 months up to 67% of patients are not adhering to their statin as prescribed? And that a leading cause …
One in five Australians – almost 5 million people – live with dry eye and of these, 800,000 suffer from severe dry eye4. An aging …
Big data is a hot topic in the Australian healthcare industry. With the Australian Institute of Health and Welfare collecting and storing government generated health …
WIN with AJP & RUM To encourage pharmacy to support the Return Unwanted Medicines (RUM) new consumer campaign, AJP has teamed up with RUM to …
Do you need more information on codeine rescheduling? Tell us what you need to know Since the decision to up-schedule codeine-containing analgesic from 1st …
Jobie Tong, Medical Affairs Manager/Regulatory Associate, AFT Pharmaceuticals and Dr Hartley Atkinson, Managing Director/CEO, AFT Pharmaceuticals Summary From 1 February 2018, all products containing codeine …
Up to 90% of patients using an inhaler device don’t use it correctly and won’t be getting the best possible benefit from their medicine. The …
Developed with Community Pharmacy, for Community Pharmacy the one Platform, one Solution GuildCare NG and integrated patient app, myPharmacyLink, provides pharmacy one easy to use …
